Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B by Fuino Lianne, Bali Purva, Wittmann Sylvie, Donapaty Sreenivas, Guo Fei, Yamaguchi Hirohito, Wang Hong-Gang, Atadja Peter, Bhalla Kapil in Molecular cancer therapeutics (2003).

[PMID: 14578462] PubMed


Discussed In Paper


Rx Annotations

No dosing information annotated.